<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00475891</url>
  </required_header>
  <id_info>
    <org_study_id>PRO07050007</org_study_id>
    <nct_id>NCT00475891</nct_id>
  </id_info>
  <brief_title>Determination of Genetic Relatedness of Linezolid-resistant Vancomycin-resistant Enterococci (VRE) Surveillance Cultures</brief_title>
  <official_title>Determination of Genetic Relatedness of Linezolid-resistant Vancomycin-resistant Enterococci (VRE) Surveillance Cultures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will help in identifying the best empiric antibiotic option for Linezolid resistant
      Vancomycin-resistant Enterococci (VRE) infections. This research is important because it
      allows the determination of resistance rates to antibiotics that may not be frequently tested
      to by the clinical microbiology laboratory at UPMC-Presbyterian. It also will provide
      antibiotic minimum inhibitory concentrations (MICs) for these pathogens which may help in
      identifying the best empiric antibiotic option for Linezolid-resistant VRE infections.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After 20 linezolid-resistant VRE isolates are identified, genetic relatedness will be
      determined using a method known as Pulse-field gel electrophoresis (PFGE). No patient related
      data will accompany these isolates, nor will any related identifiers. These isolates will be
      tested using standardized susceptibility methods. We will then grow each isolate and test via
      approved laboratory standards (E-test, AB Biodisk, Stockholm, Sweden) to the drug linezolid.
      Those determined to be resistant using this approved methodology will be saved until 20
      isolates are identified. For resistant isolates found, analytical and molecular techniques
      will be performed to determine the mechanisms of resistance and whether resistant isolates
      are coming from a single source/being transmitted from person to person.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>dead or alive</measure>
    <time_frame>end of study</time_frame>
    <description>health status</description>
  </primary_outcome>
  <enrollment type="Actual">20</enrollment>
  <condition>Isolate</condition>
  <condition>Linezolid</condition>
  <eligibility>
    <study_pop>
      <textblock>
        isolates for rectal surveillance
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Dr. Harrison's laboratory collected the rectal surveillance isolates for infection
             control purposes. The isolates will be from January 1, 2006 to December 31, 2006.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian Potoski, Pharm D</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 17, 2007</study_first_submitted>
  <study_first_submitted_qc>May 18, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2007</study_first_posted>
  <last_update_submitted>December 5, 2014</last_update_submitted>
  <last_update_submitted_qc>December 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>isolate</keyword>
  <keyword>infection</keyword>
  <keyword>linezolid</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vancomycin</mesh_term>
    <mesh_term>Linezolid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

